22nd-29th April 2024

Wolfhard Erdlenbruch

Data is a critical tool to improve the lives of patients in myriad ways. Our efforts to support patients with PID do not stop with the development of transformative plasma-derived therapies that many PID patients rely on. At Takeda, we are also working on projects to develop diagnostic algorithms for early identification of PID, simplify monitoring IG levels in PID patients, and characterize PID patients for optimal and individualized treatment and care, among others. Thereby, we hope to use data to help identify and address unmet needs and improve the lives of patients in a holistic way.